Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.62B |
| 2 |
NVIDIA
NVDA
|
+$2.91B |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$841M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$614M |
| 5 |
Apple
AAPL
|
+$435M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$379M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$341M |
| 3 |
Kenvue
KVUE
|
+$281M |
| 4 |
Linde
LIN
|
+$273M |
| 5 |
DoorDash
DASH
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.55% |
| 2 | Technology | 2.96% |
| 3 | Consumer Discretionary | 1.26% |
| 4 | Financials | 0.68% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VLD
11001
PUT
DELISTED
Velo3D, Inc.
VLD
| $127K | ﹤0.01% |
7,869
-1,134
| -13% | -$12.8K |
|
|
GRCE
11002
Grace Therapeutics
GRCE
$44.6M
| $126K | ﹤0.01% |
+36,650
| New | +$108K |
|
11003
Beyond Air
XAIR
$4.41M
| $126K | ﹤0.01% |
182
+30
| +20% | +$20.6K |
|
11004
PUT
Enviri
NVRI
$628M
| $126K | ﹤0.01% |
+13,800
| New | +$116K |
|
11005
Claros Mortgage Trust
CMTG
$229M
| $126K | ﹤0.01% |
12,937
-38,894
| -75% | -$421K |
|
11006
PUT
Verastem
VSTM
$654M
| $126K | ﹤0.01% |
+10,700
| New | +$124K |
|
11007
PUT
ALX Oncology
ALXO
$277M
| $126K | ﹤0.01% |
11,300
-42,600
| -79% | -$598K |
|
11008
CALL
Karyopharm Therapeutics
KPTI
$42.4M
| $126K | ﹤0.01% |
5,553
+1,766
| +47% | +$31K |
|
11009
BGC Group
BGC
$5.76B
| $126K | ﹤0.01% |
16,173
-560,555
| -97% | -$4.16M |
|
11010
PUT
Angi Inc
ANGI
$204M
| $125K | ﹤0.01% |
+4,790
| New | +$122K |
|
11011
First Guaranty Bancshares
FGBI
$144M
| $125K | ﹤0.01% |
12,347
+37
| +0.3% | +$423 |
|
11012
Team
TISI
$113M
| $125K | ﹤0.01% |
17,338
-1
| -0% | -$6 |
|
11013
Erasca
ERAS
$6.31B
| $125K | ﹤0.01% |
60,506
-1,248
| -2% | -$2.49K |
|
11014
PUT
Delcath Systems
DCTH
$567M
| $124K | ﹤0.01% |
26,100
+12,300
| +89% | +$53.1K |
|
|
OMGA
11015
CALL
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $124K | ﹤0.01% |
34,100
+16,700
| +96% | +$64K |
|
11016
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$215M
| $124K | ﹤0.01% |
10,212
-25,019
| -71% | -$321K |
|
11017
PUT
Brookdale Senior Living
BKD
$2.8B
| $124K | ﹤0.01% |
18,800
-56,400
| -75% | -$329K |
|
|
RAPT
11018
CALL
DELISTED
RAPT Therapeutics
RAPT
| $124K | ﹤0.01% |
1,725
-14,450
| -89% | -$2.01M |
|
11019
Gold Royalty Corp
GROY
$769M
| $124K | ﹤0.01% |
65,897
-20,740
| -24% | -$33.4K |
|
11020
PUT
GH Research
GHRS
$1.92B
| $124K | ﹤0.01% |
+11,600
| New | +$92.1K |
|
|
TTOO
11021
DELISTED
T2 Biosystems, Inc
TTOO
| $123K | ﹤0.01% |
41,166
-13,838
| -25% | -$64.7K |
|
11022
CALL
Bakkt Inc
BKKT
$347M
| $123K | ﹤0.01% |
10,728
-4,284
| -29% | -$115K |
|
|
WPRT
11023
CALL
Westport Fuel Systems
WPRT
$35M
| $123K | ﹤0.01% |
18,300
+5,500
| +43% | +$33.4K |
|
|
INZY
11024
PUT
DELISTED
Inozyme Pharma
INZY
| $123K | ﹤0.01% |
+16,100
| New | +$88.3K |
|
|
ENFN
11025
DELISTED
Enfusion, Inc.
ENFN
| $123K | ﹤0.01% |
13,331
-11,167
| -46% | -$98.3K |
|
Similar funds
Jeff Yass's Q1 2024 Portfolio in Review
As of Q1 2024, Jeff Yass held 13,901 positions worth $576B, up 9.6% from $525B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q1 2024 filing shows 1,661 new, 4,870 increased, 5,404 reduced and 1,849 closed positions. Its largest new stake was Grayscale Bitcoin Trust: 19,119,358 shares worth $1.09B. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $379M.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2024 buy was Grayscale Bitcoin Trust: 19,119,358 shares worth $1.09B.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $3.62B increase.
- Jeff Yass's biggest Q1 2024 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $379M.
- Jeff Yass fully exited WisdomTree Japan Hedged Equity Fund in Q1 2024, selling an estimated $34.5M.
- Jeff Yass's ten largest holdings make up 25% of its $576B portfolio in Q1 2024.
- Jeff Yass opened 1,661 new positions and closed 1,849 in Q1 2024.
- Jeff Yass's portfolio value rose 9.6% quarter-over-quarter to $576B.
Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.